What is the end product of purine metabolism in humans?
Which enzyme polymerises Okazaki fragments?
A frameshift mutation does not affect the complete amino acid sequence if it occurs in multiples of what number?
Which type of RNA is most commonly associated with pseudouridine?
Which type of DNA polymerase is responsible for the replication of mitochondrial DNA?
Which type of RNA is primarily involved in gene silencing?
What does salvage purine synthesis refer to?
Rate limiting step in pyrimidine synthesis?
What is the primary role of telomerase in cellular biology?
What does Chargaff's rule state regarding the base pairing in DNA?
Explanation: ***Uric acid*** - **Uric acid** is the final breakdown product of **purine metabolism** in humans. - It is formed from the degradation of **adenosine** and **guanosine**, with xanthine oxidase playing a key role in its synthesis. *Allantoin* - **Allantoin** is the end product of **purine metabolism** in most mammals other than primates, as they possess the enzyme **uricase** to further break down uric acid. - Humans lack **uricase**, hence allantoin is not the end product in humans. *Carbon Dioxide* - **Carbon dioxide** is a major end product of **carbohydrate** and **fat metabolism** through cellular respiration. - It is not directly associated with the degradation pathway of purines. *None of the options* - This option is incorrect because **uric acid** is indeed the definitive end product of purine metabolism in humans.
Explanation: ***DNA polymerase III*** - **DNA polymerase III** is the primary replicative enzyme in **prokaryotes (bacteria)** responsible for synthesizing new DNA strands, including the **polymerization of Okazaki fragments** on the lagging strand. - It possesses high processivity (can add ~500 nucleotides without dissociating), essential for rapid and efficient DNA synthesis during replication, adding nucleotides in a **5' to 3' direction**. - In **eukaryotes**, DNA polymerase δ (delta) performs the analogous function of polymerizing Okazaki fragments. *DNA polymerase I* - **DNA polymerase I** in prokaryotes primarily functions in **removing RNA primers** left by primase and **filling the resulting gaps** with DNA nucleotides. - It has 5' to 3' exonuclease activity for primer removal and polymerase activity for gap filling, but is **not the main enzyme for elongating Okazaki fragments**. - Its role is in **DNA repair and finishing replication**, not the extensive synthesis of Okazaki fragments. *DNA polymerase II* - **DNA polymerase II** in prokaryotes is primarily involved in **DNA repair mechanisms**, particularly in **restarting stalled replication forks** and responding to DNA damage. - It is not the main enzyme responsible for the polymerization of **Okazaki fragments** during normal DNA replication. *RNA polymerase* - **RNA polymerase** (specifically **primase**, a specialized RNA polymerase) synthesizes short **RNA primers** (8-12 nucleotides) during DNA replication, which provide the 3'-OH group necessary to initiate DNA synthesis. - It does not synthesize DNA or polymerize **Okazaki fragments**; its function is to create RNA primers, not extend DNA strands.
Explanation: ***3*** - A **frameshift mutation** occurs when nucleotides are inserted or deleted in a number not divisible by three, altering the **reading frame** of the codons. - If insertions or deletions occur in multiples of **three**, the reading frame is restored after the mutation, largely preserving the downstream amino acid sequence. *1* - An insertion or deletion of a single nucleotide (1) definitively causes a **frameshift mutation**. - This alters all subsequent **codons**, leading to a completely different amino acid sequence downstream from the mutation. *2* - An insertion or deletion of two nucleotides (2) also results in a **frameshift mutation**. - This change shifts the **reading frame**, leading to the production of an altered protein or a premature stop codon. *None of the options* - This option is incorrect because a specific number, **three**, can allow for a frameshift mutation to not affect the complete amino acid sequence. - Multiples of three maintain the original **reading frame** (although potentially adding or removing a specific amino acid), whereas other numbers guarantee a frameshift.
Explanation: ***Transfer RNA (tRNA)*** - **Pseudouridine (ψ)** is one of the most abundant modified nucleosides in RNA, and **tRNA contains the highest proportion** of pseudouridine modifications among all RNA types. - **tRNA molecules can contain up to 10-15% modified bases**, with pseudouridine being particularly abundant in the **TψC arm** (thymine-pseudouridine-cytosine loop). - These modifications are critical for **tRNA stability, proper folding, and accurate codon-anticodon recognition** during translation. - Pseudouridine enhances base stacking and stabilizes RNA structure through additional hydrogen bonding capability. *Ribosomal RNA (rRNA)* - While rRNA does contain pseudouridine modifications, they are present in **lower proportions compared to tRNA**. - rRNA pseudouridine modifications do play important roles in **ribosomal assembly and function**, but tRNA remains the RNA type most commonly associated with this modification. *Messenger RNA (mRNA)* - **mRNA is generally much less modified** than tRNA or rRNA. - Pseudouridine modifications in mRNA are relatively rare in prokaryotes and were only recently discovered to be more common in eukaryotic mRNA. - When present, they may affect **mRNA stability and translation efficiency**. *DNA* - **DNA does not contain pseudouridine** as this is an RNA-specific modification. - Pseudouridine is formed by **post-transcriptional isomerization** of uridine residues in RNA.
Explanation: ***DNA polymerase gamma*** - **DNA polymerase gamma** is the sole DNA polymerase responsible for replicating and repairing the mitochondrial DNA in eukaryotic cells. - It consists of a large catalytic subunit and two smaller accessory subunits that provide **proofreading** and processivity functions. *DNA polymerase alpha* - **DNA polymerase alpha** is primarily involved in initiating DNA replication on both the leading and lagging strands of nuclear DNA. - It forms a complex with **primase** to synthesize short RNA primers followed by a short stretch of DNA. *DNA polymerase delta* - **DNA polymerase delta** is a key enzyme in nuclear DNA replication, primarily responsible for the **elongation of the lagging strand**. - It also plays a significant role in various DNA repair pathways, including **nucleotide excision repair**. *DNA polymerase beta* - **DNA polymerase beta** is mainly involved in **DNA repair processes**, specifically **base excision repair (BER)** in the nucleus. - It has a low processivity and lacks **proofreading activity**, making it unsuitable for bulk DNA replication.
Explanation: ***miRNA*** - **miRNA** (microRNA) is a small non-coding RNA molecule that plays a crucial role in **post-transcriptional regulation of gene expression**. - It functions by binding to complementary messenger RNA (mRNA) molecules, leading to **mRNA degradation** or **inhibition of translation**, thereby silencing genes. - miRNA is the primary RNA type involved in **gene silencing** through the RNA interference (RNAi) pathway. *rRNA* - **rRNA** (ribosomal RNA) is a primary component of **ribosomes**, the cellular machinery responsible for protein synthesis. - Its main function is to **catalyze peptide bond formation** and provide structural integrity to the ribosome, not gene silencing. *tRNA* - **tRNA** (transfer RNA) is responsible for carrying specific **amino acids** to the ribosome during protein synthesis. - It acts as an adapter molecule, translating the **genetic code** in mRNA into an amino acid sequence. *mRNA* - **mRNA** (messenger RNA) carries genetic information from **DNA to ribosomes** for protein synthesis. - While mRNA can be targeted by gene silencing mechanisms (like miRNA), it is not the RNA type that performs the silencing function itself.
Explanation: ***Synthesis of purine nucleotides from purine bases*** - **Salvage pathways** recycle pre-existing purine or pyrimidine bases (from nucleic acid degradation) by re-attaching them to a **ribose phosphate** to form a new nucleotide. - This process is energy-efficient as it bypasses several steps of the de novo synthesis pathway, utilizing enzymes like **adenine phosphoribosyltransferase (APRT)** and **hypoxanthine-guanine phosphoribosyltransferase (HGPRT)**. *Synthesis of purine nucleotides from ribose-5-phosphate.* - While **ribose-5-phosphate** is a precursor, the complete synthesis from this molecule is part of the **de novo pathway**, which starts with PRPP (phosphoribosyl pyrophosphate) formation from ribose-5-phosphate. - This option does not specify the direct reuse of a pre-formed purine base, which is the hallmark of salvage. *Synthesis of purine nucleotides from simple precursors (de novo synthesis).* - **De novo synthesis** is the creation of nucleotides from scratch using simple metabolic precursors like amino acids (glycine, aspartate, glutamine), CO2, and THF derivatives. - This contrasts with salvage pathways, which recycle existing bases. *Synthesis of purine nucleotides from degraded RNA.* - Degraded RNA breaks down into **nucleotides**, which can then be further broken down into **purine bases** and ribose phosphates. - The direct synthesis of purine nucleotides from *degraded RNA* involves recovering the individual bases or nucleosides, then converting them to nucleotides via salvage, not directly using the entire degraded RNA.
Explanation: ***Carbamoyl phosphate synthetase II (CPS-II)*** - **CPS-II** is the **committed and rate-limiting enzyme** in **de novo pyrimidine synthesis** in **mammals (including humans)** - It catalyzes the formation of **carbamoyl phosphate** from glutamine, CO₂, and 2 ATP in the **cytoplasm** - This is the **first committed step** and the main **regulatory checkpoint**, inhibited by UTP (feedback inhibition) and activated by PRPP and ATP - CPS-II is part of the **CAD complex** (carbamoyl phosphate synthetase, aspartate transcarbamoylase, dihydroorotase) in mammals *Aspartate transcarbamoylase (ATCase)* - ATCase catalyzes the **second step**: condensation of carbamoyl phosphate with aspartate to form carbamoyl aspartate - While ATCase is the **rate-limiting step in bacteria** (E. coli), in **mammals** it is part of the CAD complex and **not the primary regulatory step** - This option is incorrect for human/mammalian biochemistry tested in NEET PG *Dihydro-orotase* - The **third enzyme** in the pathway, converting carbamoyl aspartate to dihydroorotate - Part of the CAD complex in mammals but **not the rate-limiting step** *Dihydroorotate dehydrogenase* - Catalyzes the **fourth step**: oxidation of dihydroorotate to orotate - Located on the **outer surface of the inner mitochondrial membrane** (only mitochondrial enzyme in the pathway) - Important enzyme but **not rate-limiting**
Explanation: ***It contributes to cellular immortality*** - Telomerase maintains **telomere length** in stem cells and cancer cells, allowing them to divide indefinitely without undergoing senescence. - This activity is crucial for the **immortality** observed in certain cell types and the unchecked proliferation characteristic of cancer. - This is the **primary functional role** of telomerase in cellular biology. *It is a reverse transcriptase that adds DNA sequences* - While telomerase is indeed a **reverse transcriptase**, this describes its **mechanism of action** rather than its primary cellular role. - Its specific role is to add repetitive **telomeric DNA sequences** (TTAGGG repeats) to chromosome ends, maintaining telomere length. *It is present in most somatic cells* - **Telomerase activity** is generally very low or absent in most differentiated somatic cells. - This limited activity contributes to the **Hayflick limit** and cellular aging, as telomeres shorten with each cell division. *It is absent in most somatic cells* - While telomerase activity is **low or undetectable** in the vast majority of differentiated somatic cells, it is not entirely absent in all of them. - Some somatic cells, like certain progenitor cells, may retain very **minimal telomerase activity**, although not enough to prevent telomere shortening over time. - The more accurate statement is that it has "low or absent activity" rather than being completely absent.
Explanation: ***A=T, G=C*** - **Chargaff's rules** state that in any double-stranded DNA, the amount of **adenine (A)** is approximately equal to the amount of **thymine (T)**, and the amount of **guanine (G)** is approximately equal to the amount of **cytosine (C)**. - This equivalency reflects the specific **base pairing** in the DNA double helix, where A always pairs with T, and G always pairs with C. *A=G, T=C* - This statement is incorrect as it proposes an atypical and biologically inaccurate pairing between a **purine (A)** and another **purine (G)**, and a **pyrimidine (T)** with a **pyrimidine (C)**. - This combination would disrupt the uniform diameter of the DNA double helix required for its structural stability. *A=C, G=T* - This option is incorrect because it suggests pairing a purine (A) with a pyrimidine (C) and a purine (G) with a pyrimidine (T) in a way that is not observed in natural DNA. - Such pairings would also lead to an irregular width of the DNA molecule, destabilizing its structure. *Any combination possible* - This statement is false; base pairing in DNA is **highly specific** and not random due to chemical and structural constraints. - The specific pairing rules (**A with T, G with C**) are crucial for maintaining the consistent structure of the DNA double helix and for accurate DNA replication and transcription.
Nucleotide Structure and Function
Practice Questions
DNA Structure and Replication
Practice Questions
RNA Structure and Types
Practice Questions
Transcription: RNA Synthesis
Practice Questions
Post-Transcriptional Modifications
Practice Questions
Translation: Protein Synthesis
Practice Questions
Genetic Code and Codon Usage
Practice Questions
Regulation of Gene Expression
Practice Questions
Mutations and DNA Repair
Practice Questions
Purine Metabolism and Disorders
Practice Questions
Pyrimidine Metabolism and Disorders
Practice Questions
Nucleotide Degradation and Salvage Pathways
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free